Randall Michael Giuffre has bought DMAC on 6 days since Dec 2018
Director at DiaMedica Therapeutics Inc.
SEC CIK 0001759822 · Filings on SEC.gov ↗
$559KBought
$0Sold
Jun 26Last buy
Randall Michael Giuffre's record
3 months after each buy, from the first price a copier could get.
+11.7%Average
+12.7 ptsVs S&P 500
3 of 4Higher
4 buys since 2018 with 3 months of prices.
Every filing
6 filings since Dec 2018, newest first
DMACBuy
Diamedica Therapeutics Inc.
Director
$254K+20.0%Jun 26
DMACBuy
Diamedica Therapeutics Inc.
Director
$81K+23.0%Dec 12
DMACBuy
Diamedica Therapeutics Inc.
Director
$35K+11.0%Dec 8
DMACBuy
Diamedica Therapeutics Inc.
Director
$80K+32.0%Dec 1
DMACBuy
Diamedica Therapeutics Inc.
Director
$64K+9.0%Nov 23
DMACBuy
Diamedica Therapeutics Inc.
Director
$45K+7.0%Dec 11
Filings come from SEC EDGAR. Not investment advice.